Latest Breaking News On - Impact biomedicines - Page 1 : comparemela.com

SynOx Therapeutics announces $75m Series B round to fund Phase 3 trial of potential best-in-class treatment for TGCT

SynOx Therapeutics announces $75m Series B round to fund Phase 3 trial of potential best-in-class treatment for TGCT
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Reggio emiliaEmilia romagnaCity ofUnited kingdomSanofi genzymeDirk kerstenDennis riedlGray barlowJon edwardsCarlo incertiPrnewswire synox therapeutics limitedSynox therapeuticsUniversity of modenaUniversity of north carolinaPhathom pharmaceuticalsCheckmate pharmaceuticals

Incyte (INCY) to Acquire Villaris Therapeutics and Auremolimab (VM6)

Incyte (INCY) to Acquire Villaris Therapeutics and Auremolimab (VM6)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNorth carolinaNick williamsJohne harrisCatalina lovemanMiro bioChristine chiouJohn harrisExchange commissionStrategic communicationsJanssen pharmaceuticalsUniversity of massachusetts chan medical schoolCentessa pharmaceuticalsWall streetVillaris therapeuticsChief executive officer

Incyte Announces Agreement to Acquire Medicxi-backed Villaris Therapeutics and Auremolimab (VM6), an Anti-IL-15Rβ Monoclonal Antibody

Incyte Announces Agreement to Acquire Medicxi-backed Villaris Therapeutics and Auremolimab (VM6), an Anti-IL-15Rβ Monoclonal Antibody
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNorth carolinaNick williamsJohne harrisCatalina lovemanMiro bioChristine chiouJohn harrisExchange commissionStrategic communicationsJanssen pharmaceuticalsUniversity of massachusetts chan medical schoolCentessa pharmaceuticalsVillaris therapeuticsChief executive officerMassachusetts chan medical school

Nine Square Therapeutics Appoints John Hood to Board of Directors

/PRNewswire/ Nine Square Therapeutics, a biotechnology company applying computational chemistry and machine-learning enabled cell profiling to discover and.

United statesUniversity of california san franciscoJohn hoodBristol myers squibbRobert paulResearch at targegenTexasam universitySquare therapeuticsNine squareNine square therapeuticsExecutive chairmanEndeavor biomedicinesImpact biomedicinesApple tree partnersCalifornia san francisco

San Diego s Endeavor BioMedicines nets $101M to hunt down genetic culprits of cancer

Biotech startup, launched in 2021, is pursuing a pipeline of precision medicines in oncology and idiopathic pulmonary fibrosis.

John hoodCelgene corpAndrew lam groupEndeavor biomedicinesSan diego based endeavorImpact biomedicinesAlly bridge groupPerceptive advisorsPiper heartland healthcare capitalRevelation partnersTekla capital managementOmega fundsLongitude capitalAndrew lamRally bridge